Current research highlights the true mechanisms of CPT1A involvement in lipid reprogramming and this may serve as a new platform for the development of molecular-targeted treatment in order to improve the therapeutic effects of radiation in NPC. This evidence concerns the gene CPT1A and nasopharyngeal carcinoma.